Intrinsic value of Rite Aid - RAD

Previous Close

$1.20

  Intrinsic Value

$1.27

stock screener

  Rating & Target

hold

+6%

Previous close

$1.20

 
Intrinsic value

$1.27

 
Up/down potential

+6%

 
Rating

hold

We calculate the intrinsic value of RAD stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 0001), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 1.3

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
   2
   3
   4
   5
   6
   7
   8
   9
   10
   11
   12
   13
   14
   15
   16
   17
   18
   19
   20
   21
   22
   23
   24
   25
   26
   27
   28
   29
   30
   31

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  2.00
  2.30
  2.57
  2.81
  3.03
  3.23
  3.41
  3.57
  3.71
  3.84
  3.95
  4.06
  4.15
  4.24
  4.31
  4.38
  4.44
  4.50
  4.55
  4.59
  4.64
  4.67
  4.70
  4.73
  4.76
  4.78
  4.81
  4.83
  4.84
  4.86
Revenue, $m
  21,960
  22,465
  23,042
  23,690
  24,408
  25,196
  26,054
  26,983
  27,984
  29,058
  30,207
  31,433
  32,738
  34,126
  35,598
  37,158
  38,809
  40,555
  42,400
  44,349
  46,404
  48,572
  50,857
  53,265
  55,801
  58,470
  61,281
  64,238
  67,349
  70,621
Variable operating expenses, $m
  20,550
  21,018
  21,553
  22,154
  22,819
  23,550
  24,345
  25,205
  26,133
  27,128
  27,991
  29,128
  30,337
  31,623
  32,987
  34,432
  35,963
  37,581
  39,291
  41,096
  43,001
  45,010
  47,127
  49,358
  51,708
  54,182
  56,786
  59,526
  62,409
  65,441
Fixed operating expenses, $m
  1,270
  1,298
  1,327
  1,356
  1,386
  1,416
  1,448
  1,479
  1,512
  1,545
  1,579
  1,614
  1,649
  1,686
  1,723
  1,761
  1,799
  1,839
  1,879
  1,921
  1,963
  2,006
  2,050
  2,096
  2,142
  2,189
  2,237
  2,286
  2,336
  2,388
Total operating expenses, $m
  21,820
  22,316
  22,880
  23,510
  24,205
  24,966
  25,793
  26,684
  27,645
  28,673
  29,570
  30,742
  31,986
  33,309
  34,710
  36,193
  37,762
  39,420
  41,170
  43,017
  44,964
  47,016
  49,177
  51,454
  53,850
  56,371
  59,023
  61,812
  64,745
  67,829
Operating income, $m
  139
  148
  162
  180
  203
  230
  262
  299
  339
  385
  636
  691
  752
  817
  888
  965
  1,047
  1,135
  1,230
  1,332
  1,440
  1,556
  1,680
  1,811
  1,951
  2,100
  2,258
  2,425
  2,603
  2,792
EBITDA, $m
  618
  633
  654
  681
  713
  750
  793
  841
  894
  953
  1,018
  1,089
  1,165
  1,248
  1,338
  1,434
  1,537
  1,648
  1,766
  1,892
  2,027
  2,170
  2,322
  2,484
  2,656
  2,838
  3,032
  3,237
  3,454
  3,684
Interest expense (income), $m
  410
  207
  216
  227
  239
  252
  267
  284
  302
  321
  342
  365
  389
  414
  442
  471
  501
  534
  569
  605
  644
  685
  728
  773
  821
  871
  924
  980
  1,039
  1,101
  1,166
Earnings before tax, $m
  -68
  -68
  -65
  -58
  -49
  -37
  -21
  -3
  18
  43
  272
  303
  337
  376
  417
  463
  513
  567
  625
  688
  756
  828
  907
  990
  1,080
  1,175
  1,277
  1,386
  1,502
  1,626
Tax expense, $m
  0
  0
  0
  0
  0
  0
  0
  0
  5
  12
  73
  82
  91
  101
  113
  125
  138
  153
  169
  186
  204
  224
  245
  267
  291
  317
  345
  374
  406
  439
Net income, $m
  -68
  -68
  -65
  -58
  -49
  -37
  -21
  -3
  13
  31
  198
  221
  246
  274
  305
  338
  374
  414
  456
  502
  552
  605
  662
  723
  788
  858
  932
  1,012
  1,097
  1,187

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  9,169
  9,380
  9,621
  9,891
  10,191
  10,520
  10,879
  11,267
  11,684
  12,133
  12,613
  13,124
  13,669
  14,249
  14,863
  15,515
  16,204
  16,933
  17,704
  18,517
  19,375
  20,281
  21,235
  22,240
  23,299
  24,414
  25,587
  26,822
  28,121
  29,487
Adjusted assets (=assets-cash), $m
  9,169
  9,380
  9,621
  9,891
  10,191
  10,520
  10,879
  11,267
  11,684
  12,133
  12,613
  13,124
  13,669
  14,249
  14,863
  15,515
  16,204
  16,933
  17,704
  18,517
  19,375
  20,281
  21,235
  22,240
  23,299
  24,414
  25,587
  26,822
  28,121
  29,487
Revenue / Adjusted assets
  2.395
  2.395
  2.395
  2.395
  2.395
  2.395
  2.395
  2.395
  2.395
  2.395
  2.395
  2.395
  2.395
  2.395
  2.395
  2.395
  2.395
  2.395
  2.395
  2.395
  2.395
  2.395
  2.395
  2.395
  2.395
  2.395
  2.395
  2.395
  2.395
  2.395
Average production assets, $m
  2,635
  2,696
  2,765
  2,843
  2,929
  3,024
  3,127
  3,238
  3,358
  3,487
  3,625
  3,772
  3,929
  4,095
  4,272
  4,459
  4,657
  4,867
  5,088
  5,322
  5,569
  5,829
  6,103
  6,392
  6,696
  7,016
  7,354
  7,709
  8,082
  8,475
Working capital, $m
  856
  876
  899
  924
  952
  983
  1,016
  1,052
  1,091
  1,133
  1,178
  1,226
  1,277
  1,331
  1,388
  1,449
  1,514
  1,582
  1,654
  1,730
  1,810
  1,894
  1,983
  2,077
  2,176
  2,280
  2,390
  2,505
  2,627
  2,754
Total debt, $m
  3,540
  3,714
  3,912
  4,134
  4,381
  4,651
  4,946
  5,264
  5,608
  5,976
  6,371
  6,792
  7,240
  7,716
  8,221
  8,756
  9,323
  9,922
  10,556
  11,224
  11,930
  12,674
  13,458
  14,285
  15,155
  16,071
  17,036
  18,051
  19,118
  20,242
Total liabilities, $m
  7,537
  7,710
  7,908
  8,131
  8,377
  8,648
  8,942
  9,261
  9,605
  9,973
  10,367
  10,788
  11,236
  11,712
  12,218
  12,753
  13,320
  13,919
  14,552
  15,221
  15,927
  16,671
  17,455
  18,281
  19,152
  20,068
  21,032
  22,047
  23,115
  24,238
Total equity, $m
  1,632
  1,670
  1,713
  1,761
  1,814
  1,873
  1,936
  2,005
  2,080
  2,160
  2,245
  2,336
  2,433
  2,536
  2,646
  2,762
  2,884
  3,014
  3,151
  3,296
  3,449
  3,610
  3,780
  3,959
  4,147
  4,346
  4,554
  4,774
  5,005
  5,249
Total liabilities and equity, $m
  9,169
  9,380
  9,621
  9,892
  10,191
  10,521
  10,878
  11,266
  11,685
  12,133
  12,612
  13,124
  13,669
  14,248
  14,864
  15,515
  16,204
  16,933
  17,703
  18,517
  19,376
  20,281
  21,235
  22,240
  23,299
  24,414
  25,586
  26,821
  28,120
  29,487
Debt-to-equity ratio
  2.170
  2.220
  2.280
  2.350
  2.410
  2.480
  2.550
  2.630
  2.700
  2.770
  2.840
  2.910
  2.980
  3.040
  3.110
  3.170
  3.230
  3.290
  3.350
  3.410
  3.460
  3.510
  3.560
  3.610
  3.650
  3.700
  3.740
  3.780
  3.820
  3.860
Adjusted equity ratio
  0.178
  0.178
  0.178
  0.178
  0.178
  0.178
  0.178
  0.178
  0.178
  0.178
  0.178
  0.178
  0.178
  0.178
  0.178
  0.178
  0.178
  0.178
  0.178
  0.178
  0.178
  0.178
  0.178
  0.178
  0.178
  0.178
  0.178
  0.178
  0.178
  0.178

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  -68
  -68
  -65
  -58
  -49
  -37
  -21
  -3
  13
  31
  198
  221
  246
  274
  305
  338
  374
  414
  456
  502
  552
  605
  662
  723
  788
  858
  932
  1,012
  1,097
  1,187
Depreciation, amort., depletion, $m
  479
  485
  492
  500
  509
  519
  530
  542
  555
  568
  382
  397
  414
  431
  450
  469
  490
  512
  536
  560
  586
  614
  642
  673
  705
  739
  774
  811
  851
  892
Funds from operations, $m
  411
  417
  428
  442
  460
  483
  509
  539
  568
  599
  580
  618
  660
  705
  754
  807
  865
  926
  992
  1,062
  1,138
  1,218
  1,304
  1,396
  1,493
  1,596
  1,706
  1,823
  1,947
  2,079
Change in working capital, $m
  17
  20
  23
  25
  28
  31
  33
  36
  39
  42
  45
  48
  51
  54
  57
  61
  64
  68
  72
  76
  80
  85
  89
  94
  99
  104
  110
  115
  121
  128
Cash from operations, $m
  394
  397
  405
  417
  432
  452
  475
  503
  529
  558
  535
  570
  609
  651
  697
  747
  800
  858
  920
  986
  1,058
  1,134
  1,215
  1,302
  1,394
  1,492
  1,597
  1,708
  1,826
  1,951
Maintenance CAPEX, $m
  -272
  -277
  -284
  -291
  -299
  -308
  -318
  -329
  -341
  -353
  -367
  -382
  -397
  -414
  -431
  -450
  -469
  -490
  -512
  -536
  -560
  -586
  -614
  -642
  -673
  -705
  -739
  -774
  -811
  -851
New CAPEX, $m
  -54
  -61
  -69
  -78
  -86
  -95
  -103
  -111
  -120
  -129
  -138
  -147
  -157
  -166
  -177
  -187
  -198
  -210
  -221
  -234
  -247
  -260
  -274
  -289
  -304
  -320
  -337
  -355
  -373
  -393
Cash from investing activities, $m
  -326
  -338
  -353
  -369
  -385
  -403
  -421
  -440
  -461
  -482
  -505
  -529
  -554
  -580
  -608
  -637
  -667
  -700
  -733
  -770
  -807
  -846
  -888
  -931
  -977
  -1,025
  -1,076
  -1,129
  -1,184
  -1,244
Free cash flow, $m
  68
  59
  52
  48
  47
  49
  54
  62
  68
  75
  30
  42
  55
  71
  89
  110
  133
  158
  186
  217
  251
  287
  327
  370
  417
  467
  521
  579
  641
  708
Issuance/(repayment) of debt, $m
  149
  173
  198
  222
  247
  270
  295
  319
  343
  369
  394
  421
  448
  476
  505
  535
  567
  599
  633
  669
  706
  744
  784
  826
  870
  916
  964
  1,015
  1,068
  1,123
Issuance/(repurchase) of shares, $m
  99
  105
  107
  106
  102
  95
  85
  72
  61
  49
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash from financing (excl. dividends), $m  
  248
  278
  305
  328
  349
  365
  380
  391
  404
  418
  394
  421
  448
  476
  505
  535
  567
  599
  633
  669
  706
  744
  784
  826
  870
  916
  964
  1,015
  1,068
  1,123
Total cash flow (excl. dividends), $m
  316
  338
  358
  377
  396
  415
  434
  453
  473
  492
  425
  462
  503
  547
  594
  645
  699
  757
  819
  886
  956
  1,032
  1,112
  1,197
  1,287
  1,383
  1,486
  1,594
  1,709
  1,831
Retained Cash Flow (-), $m
  -99
  -105
  -107
  -106
  -102
  -95
  -85
  -72
  -74
  -80
  -85
  -91
  -97
  -103
  -109
  -116
  -123
  -130
  -137
  -145
  -153
  -161
  -170
  -179
  -188
  -198
  -209
  -220
  -231
  -243
Prev. year cash balance distribution, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
  217
  233
  250
  270
  294
  320
  349
  381
  398
  413
  339
  371
  406
  444
  485
  529
  577
  628
  682
  741
  804
  870
  942
  1,018
  1,099
  1,185
  1,277
  1,374
  1,478
  1,588
Discount rate, %
  9.50
  9.98
  10.47
  11.00
  11.55
  12.12
  12.73
  13.37
  14.04
  14.74
  15.47
  16.25
  17.06
  17.91
  18.81
  19.75
  20.74
  21.77
  22.86
  24.01
  25.21
  26.47
  27.79
  29.18
  30.64
  32.17
  33.78
  35.47
  37.24
  39.10
PV of cash for distribution, $m
  198
  192
  186
  178
  170
  161
  151
  140
  122
  104
  70
  61
  52
  44
  37
  30
  23
  18
  14
  10
  7
  5
  3
  2
  1
  1
  0
  0
  0
  0
Current shareholders' claim on cash, %
  92.8
  85.9
  79.5
  73.8
  68.8
  64.5
  61.0
  58.3
  56.2
  54.6
  54.6
  54.6
  54.6
  54.6
  54.6
  54.6
  54.6
  54.6
  54.6
  54.6
  54.6
  54.6
  54.6
  54.6
  54.6
  54.6
  54.6
  54.6
  54.6
  54.6

Rite Aid Corporation is a retail drugstore chain. The Company's segments include Retail Pharmacy and Pharmacy Services. The Company operates under The Rite Aid name. It operates approximately 4,560 stores in over 30 states across the country and in the District of Columbia. The Company's Retail Pharmacy segment consists of Rite Aid stores, RediClinic and Health Dialog. It sells brand and generic prescription drugs, as well as an assortment of front-end products, including health and beauty aids, personal care products, seasonal merchandise, and a private brand product line. Its front-end products include over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise and numerous other everyday and convenience products. The Company's Pharmacy Services segment consists of EnvisionRx, which provides a range of pharmacy benefit services.

FINANCIAL RATIOS  of  Rite Aid (RAD)

Valuation Ratios
P/E Ratio 316.1
Price to Sales 0
Price to Book 2.1
Price to Tangible Book
Price to Cash Flow 5.6
Price to Free Cash Flow -5
Growth Rates
Sales Growth Rate 6.9%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate -28.2%
Cap. Spend. - 3 Yr. Gr. Rate 2.7%
Financial Strength
Quick Ratio 12
Current Ratio 0
LT Debt to Equity 1190.2%
Total Debt to Equity 1193.6%
Interest Coverage 1
Management Effectiveness
Return On Assets 0.3%
Ret/ On Assets - 3 Yr. Avg. 18.4%
Return On Total Capital 0.1%
Ret/ On T. Cap. - 3 Yr. Avg. 16%
Return On Equity 0.7%
Return On Equity - 3 Yr. Avg. -50.9%
Asset Turnover 2.9
Profitability Ratios
Gross Margin 23.7%
Gross Margin - 3 Yr. Avg. 25.9%
EBITDA Margin 3.1%
EBITDA Margin - 3 Yr. Avg. 3.9%
Operating Margin 1.4%
Oper. Margin - 3 Yr. Avg. 2.3%
Pre-Tax Margin 0.1%
Pre-Tax Margin - 3 Yr. Avg. 0.9%
Net Profit Margin 0%
Net Profit Margin - 3 Yr. Avg. 2.8%
Effective Tax Rate 91.7%
Eff/ Tax Rate - 3 Yr. Avg. -87.2%
Payout Ratio 0%

RAD stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the RAD stock intrinsic value calculation we used $21528.968 million for the last fiscal year's total revenue generated by Rite Aid. The default revenue input number comes from 0001 income statement of Rite Aid. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our RAD stock valuation model: a) initial revenue growth rate of 2% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 9.5%, whose default value for RAD is calculated based on our internal credit rating of Rite Aid, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Rite Aid.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of RAD stock the variable cost ratio is equal to 93.6%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $1243 million in the base year in the intrinsic value calculation for RAD stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 6.1% for Rite Aid.

Corporate tax rate of 27% is the nominal tax rate for Rite Aid. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the RAD stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for RAD are equal to 12%.

Life of production assets of 9.5 years is the average useful life of capital assets used in Rite Aid operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for RAD is equal to 3.9%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $1601.01 million for Rite Aid - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 1066.81 million for Rite Aid is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Rite Aid at the current share price and the inputted number of shares is $1.3 billion.

RELATED COMPANIES Price Int.Val. Rating
CVS CVS Health 79.84 125.09  str.buy
ESRX Express Script 97.46 150.09  str.buy
WBA Walgreens Boot 82.29 130.02  str.buy
PETS PetMed Express 27.34 71.73  str.buy
SFLY Shutterfly 51.07 1,979.32  str.buy
VSI Vitamin Shoppe 8.04 10.09  sell

COMPANY NEWS

▶ Why Rite Aid Is Down 35% in 2018   [Nov-14-18 06:02AM  Motley Fool]
▶ 3 Stocks To Watch As Healthcare Market Evolves   [Nov-05-18 08:55AM  ACCESSWIRE]
▶ 6 Great Stocks Under $6   [Oct-29-18 09:01AM  Motley Fool]
▶ Did Rite Aid Stock Just Hit Rock Bottom?   [Oct-08-18 10:17AM  Motley Fool]
▶ Dow Ends Modestly Higher After Paring Early Gains   [Sep-27-18 04:06PM  TheStreet.com]
▶ [$$] Rite Aid Shakes Up Board, Reports Higher Revenue   [02:17PM  The Wall Street Journal]
▶ [$$] Rite Aid Shakes Up Board, Reports Higher Revenue in 2Q   [12:42PM  The Wall Street Journal]
▶ Rite Aid: Fiscal 2Q Earnings Snapshot   [07:13AM  Associated Press]
▶ Rite Aid Q2 Earnings Preview   [Sep-26-18 02:19PM  Benzinga]
▶ Rite Aid Stock Is Hitting New Lows at the Worst Time   [Sep-24-18 02:56PM  Motley Fool]
▶ Upcoming Earnings to Watch: NKE, RAD, BB   [Sep-21-18 02:14PM  Zacks]
▶ Deadly shooting at Maryland Rite Aid facility   [Sep-20-18 06:13PM  ABC News Videos]
▶ Rite Aid to Release Second Quarter Results on September 27   [Sep-19-18 11:56AM  Business Wire]
▶ Health Dialog Earns NCQA Certification for 24/7 Nurse Line   [Sep-18-18 10:00AM  Business Wire]
▶ Rite Aid Investors Got What They Wanted, Unfortunately   [Sep-17-18 11:07AM  Motley Fool]
▶ 5 Small-Cap Stocks for Investors Who Can Handle Risk   [Sep-12-18 12:44PM  InvestorPlace]
▶ Goldman Sachs Bearish On Standalone Rite Aid   [Sep-06-18 02:56PM  Benzinga]
▶ 7 Stocks Under $7   [Aug-22-18 08:52AM  Motley Fool]
▶ Is Rite Aid a Bad News Buy?   [Aug-17-18 09:58PM  Motley Fool]
▶ Cramer Remix: Why this stock could be red hot   [Aug-14-18 07:01PM  CNBC]
▶ Is Rite Aid Corporation a Buy?   [Aug-12-18 06:33AM  Motley Fool]
▶ [$$] The Proxy Advisers Veto   [Aug-10-18 07:48PM  The Wall Street Journal]
▶ [$$] The Proxy Advisers' Veto   [06:59PM  The Wall Street Journal]
▶ What Now, Rite Aid Investors?   [11:55AM  Motley Fool]
▶ Seasonal Flu Shots Now Available at Rite Aid   [08:00AM  Business Wire]

CONTACT US       ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2018. All rigths reserved.